cyclin E Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin E monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin E monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin E is a crucial regulatory protein that plays a significant role in the transition from the G1 phase to the S phase of the cell cycle, facilitating DNA replication. Its dysregulation is often associated with various cancers, making cyclin E a vital target for understanding tumorigenesis and developing therapeutic strategies. The study of cyclin E is essential for elucidating the mechanisms of cell proliferation and the potential for targeted cancer treatments. Cyclin E monoclonal antibodies enable researchers to investigate cell cycle checkpoints and their role in cancer development. Understanding cyclin E expression patterns and interactions provides valuable insights into cellular regulation mechanisms. Cyclin E research continues to reveal new pathways and potential therapeutic targets in cancer biology. Santa Cruz Biotechnology monoclonal antibodies for cyclin E support cutting-edge research that advances our understanding of cell cycle regulation and cancer development.